TC
BIO icon

Toews Corporation’s Bio-Rad Laboratories Class A BIO Stock Holding History

Toews Corporation’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,900
Closed -$979K – 35
2020
Q3 		$979K Buy
+1,900
New +$962K 0.3% 87

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Toews Corporation's BIO Position: Q4 2020 in Review

Toews Corporation sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 1,900 shares — an estimated $979K sold.

Toews Corporation first reported a position in BIO in Q3 2020 and held it in 1 quarter. The position peaked at $979K in Q3 2020. 490 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

  • Toews Corporation reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
  • Toews Corporation sold 1,900 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $979K.
  • Toews Corporation first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 1 quarter.
  • Toews Corporation's Bio-Rad Laboratories Class A position peaked at $979K in Q3 2020.
  • 490 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Toews Corporation's 13F filing for Q4 2020, filed 3 Feb 2021.